Amgen Inc. Increase (Decrease) in Accounts Receivable
Amgen Inc. (AMGN) reported Increase (Decrease) in Accounts Receivable of $680.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-05
- Amgen Inc. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $1.09B, a 112.23% increase year-over-year.
- Amgen Inc. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$413.00M, a 131.57% decline year-over-year.
- Amgen Inc. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $1.07B.
- Amgen Inc. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was -$222.00M, a 164.91% decline year-over-year.
- Amgen Inc. increase (decrease) in accounts receivable for fiscal 2025 was $2.68B.
- Amgen Inc. increase (decrease) in accounts receivable for fiscal 2024 was -$441.00M, a 143.45% decline from fiscal 2023.
- Amgen Inc. increase (decrease) in accounts receivable for fiscal 2023 was $1.01B, a 36.06% increase from fiscal 2022.
- Amgen Inc. increase (decrease) in accounts receivable for fiscal 2022 was $746.00M, a 73.89% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.09B derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $680.00M 10-Q · filed 2026-08-05 | $1.75B derived: sum of 3 quarters · filed 2026-08-05 | $1.53B derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$413.00M 10-Q · filed 2026-05-01 | $662.00M derived: sum of 2 quarters · filed 2026-05-01 | $440.00M derived: sum of 3 quarters · filed 2026-05-01 | $955.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $1.07B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $853.00M derived: sum of 2 quarters · filed 2026-02-13 | $1.37B derived: sum of 3 quarters · filed 2026-08-05 | $2.68B 10-K · filed 2026-02-13 |
| 2025-09-30 | -$222.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $293.00M derived: sum of 2 quarters · filed 2026-08-05 | $1.60B 10-Q · filed 2025-11-05 | $1.13B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $515.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $1.82B 10-Q · filed 2026-08-05 | $1.35B derived: sum of 3 quarters · filed 2026-08-05 | $1.69B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $1.31B 10-Q · filed 2026-05-01 | $835.00M derived: sum of 2 quarters · filed 2026-05-01 | $1.18B derived: sum of 3 quarters · filed 2026-05-01 | $1.35B derived: sum of 4 quarters · filed 2026-05-01 |
| 2024-12-31 | -$473.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | -$131.00M derived: sum of 2 quarters · filed 2026-02-13 | $45.00M derived: sum of 3 quarters · filed 2026-02-13 | -$441.00M 10-K · filed 2026-02-13 |
| 2024-09-30 | $342.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $518.00M derived: sum of 2 quarters · filed 2025-11-05 | $32.00M 10-Q · filed 2025-11-05 | $465.00M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | $176.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$310.00M 10-Q · filed 2025-08-06 | $123.00M derived: sum of 3 quarters · filed 2026-02-13 | $465.00M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | -$486.00M 10-Q · filed 2025-05-02 | -$53.00M derived: sum of 2 quarters · filed 2026-02-13 | $289.00M derived: sum of 3 quarters · filed 2026-02-13 | $385.00M derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | $433.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $775.00M derived: sum of 2 quarters · filed 2026-02-13 | $871.00M derived: sum of 3 quarters · filed 2026-02-13 | $1.01B 10-K · filed 2026-02-13 |
| 2023-09-30 | $342.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $438.00M derived: sum of 2 quarters · filed 2024-10-31 | $582.00M 10-Q · filed 2024-10-31 | $762.00M derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-06-30 | $96.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $240.00M 10-Q · filed 2024-08-07 | $420.00M derived: sum of 3 quarters · filed 2025-02-14 | $482.00M derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-03-31 | $144.00M 10-Q · filed 2024-05-03 | $324.00M derived: sum of 2 quarters · filed 2025-02-14 | $386.00M derived: sum of 3 quarters · filed 2025-02-14 | $695.00M derived: sum of 4 quarters · filed 2025-02-14 |
| 2022-12-31 | $180.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $242.00M derived: sum of 2 quarters · filed 2025-02-14 | $551.00M derived: sum of 3 quarters · filed 2025-02-14 | $746.00M 10-K · filed 2025-02-14 |
| 2022-09-30 | $62.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-31 | $371.00M derived: sum of 2 quarters · filed 2023-10-31 | $566.00M 10-Q · filed 2023-10-31 | $726.00M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-06-30 | $309.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $504.00M 10-Q · filed 2023-08-04 | $664.00M derived: sum of 3 quarters · filed 2024-02-14 | $968.00M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-03-31 | $195.00M 10-Q · filed 2023-04-28 | $355.00M derived: sum of 2 quarters · filed 2024-02-14 | $659.00M derived: sum of 3 quarters · filed 2024-02-14 | $715.00M derived: sum of 4 quarters · filed 2024-02-14 |
| 2021-12-31 | $160.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $464.00M derived: sum of 2 quarters · filed 2024-02-14 | $520.00M derived: sum of 3 quarters · filed 2024-02-14 | $429.00M 10-K · filed 2024-02-14 |
| 2021-09-30 | $304.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $360.00M derived: sum of 2 quarters · filed 2022-11-04 | $269.00M 10-Q · filed 2022-11-04 | $665.00M derived: sum of 4 quarters · filed 2023-02-09 |
| 2021-06-30 | $56.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | -$35.00M 10-Q · filed 2022-08-05 | $361.00M derived: sum of 3 quarters · filed 2023-02-09 | -$785.00M derived: sum of 4 quarters · filed 2023-02-09 |
| 2021-03-31 | -$91.00M 10-Q · filed 2022-04-28 | $305.00M derived: sum of 2 quarters · filed 2023-02-09 | -$841.00M derived: sum of 3 quarters · filed 2023-02-09 | -$619.00M derived: sum of 4 quarters · filed 2023-02-09 |
| 2020-12-31 | $396.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-09 | -$750.00M derived: sum of 2 quarters · filed 2023-02-09 | -$528.00M derived: sum of 3 quarters · filed 2023-02-09 | $427.00M 10-K · filed 2023-02-09 |
| 2020-09-30 | -$1.15B derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | -$924.00M derived: sum of 2 quarters · filed 2021-11-03 | $31.00M 10-Q · filed 2021-11-03 | $472.00M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-06-30 | $222.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $1.18B 10-Q · filed 2021-08-04 | $1.62B derived: sum of 3 quarters · filed 2022-02-16 | $1.45B derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-03-31 | $955.00M 10-Q · filed 2021-04-28 | $1.40B derived: sum of 2 quarters · filed 2022-02-16 | $1.23B derived: sum of 3 quarters · filed 2022-02-16 | $1.25B derived: sum of 4 quarters · filed 2022-02-16 |
| 2019-12-31 | $441.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $276.00M derived: sum of 2 quarters · filed 2022-02-16 | $297.00M derived: sum of 3 quarters · filed 2022-02-16 | $504.00M 10-K · filed 2022-02-16 |
| 2019-09-30 | -$165.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | -$144.00M derived: sum of 2 quarters · filed 2020-10-29 | $63.00M 10-Q · filed 2020-10-29 | $207.00M derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-06-30 | $21.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | $228.00M 10-Q · filed 2020-07-29 | $372.00M derived: sum of 3 quarters · filed 2021-02-09 | $258.00M derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-03-31 | $207.00M 10-Q · filed 2020-05-01 | $351.00M derived: sum of 2 quarters · filed 2021-02-09 | $237.00M derived: sum of 3 quarters · filed 2021-02-09 | $201.00M derived: sum of 4 quarters · filed 2021-02-09 |
| 2018-12-31 | $144.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-09 | $30.00M derived: sum of 2 quarters · filed 2021-02-09 | -$6.00M derived: sum of 3 quarters · filed 2021-02-09 | $378.00M 10-K · filed 2021-02-09 |
| 2018-09-30 | -$114.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | -$150.00M derived: sum of 2 quarters · filed 2019-10-30 | $234.00M 10-Q · filed 2019-10-30 | $63.00M derived: sum of 4 quarters · filed 2020-02-12 |
| 2018-06-30 | -$36.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | $348.00M 10-Q · filed 2019-07-31 | $177.00M derived: sum of 3 quarters · filed 2020-02-12 | $15.00M derived: sum of 4 quarters · filed 2020-02-12 |
| 2018-03-31 | $384.00M 10-Q · filed 2019-05-01 | $213.00M derived: sum of 2 quarters · filed 2020-02-12 | $51.00M derived: sum of 3 quarters · filed 2020-02-12 | $395.00M derived: sum of 4 quarters · filed 2020-02-12 |
| 2017-12-31 | -$171.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-12 | -$333.00M derived: sum of 2 quarters · filed 2020-02-12 | $11.00M derived: sum of 3 quarters · filed 2020-02-12 | $58.00M 10-K · filed 2020-02-12 |
| 2017-09-30 | -$162.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | $182.00M derived: sum of 2 quarters · filed 2018-10-31 | $229.00M 10-Q · filed 2018-10-31 | $251.00M derived: sum of 4 quarters · filed 2019-02-13 |
| 2017-06-30 | $344.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27 | $391.00M 10-Q · filed 2018-07-27 | $413.00M derived: sum of 3 quarters · filed 2019-02-13 | $486.00M derived: sum of 4 quarters · filed 2019-02-13 |
| 2017-03-31 | $47.00M 10-Q · filed 2018-04-25 | $69.00M derived: sum of 2 quarters · filed 2019-02-13 | $142.00M derived: sum of 3 quarters · filed 2019-02-13 | $163.00M derived: sum of 4 quarters · filed 2019-02-13 |
| 2016-12-31 | $22.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | $95.00M derived: sum of 2 quarters · filed 2019-02-13 | $116.00M derived: sum of 3 quarters · filed 2019-02-13 | $214.00M 10-K · filed 2019-02-13 |
| 2016-09-30 | $73.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26 | $94.00M derived: sum of 2 quarters · filed 2017-10-26 | $192.00M 10-Q · filed 2017-10-26 | $310.00M derived: sum of 4 quarters · filed 2018-02-13 |
| 2016-06-30 | $21.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-26 | $119.00M 10-Q · filed 2017-07-26 | $237.00M derived: sum of 3 quarters · filed 2018-02-13 | $340.00M derived: sum of 4 quarters · filed 2018-02-13 |
| 2016-03-31 | $98.00M 10-Q · filed 2017-04-27 | $216.00M derived: sum of 2 quarters · filed 2018-02-13 | $319.00M derived: sum of 3 quarters · filed 2018-02-13 | $509.00M derived: sum of 4 quarters · filed 2018-02-13 |
| 2015-12-31 | $118.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $221.00M derived: sum of 2 quarters · filed 2018-02-13 | $411.00M derived: sum of 3 quarters · filed 2018-02-13 | $420.00M 10-K · filed 2018-02-13 |
| 2015-09-30 | $103.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | $293.00M derived: sum of 2 quarters · filed 2016-10-28 | $302.00M 10-Q · filed 2016-10-28 | $511.00M derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-06-30 | $190.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-29 | $199.00M 10-Q · filed 2016-07-29 | $408.00M derived: sum of 3 quarters · filed 2017-02-14 | $63.00M derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-03-31 | $9.00M 10-Q · filed 2016-05-02 | $218.00M derived: sum of 2 quarters · filed 2017-02-14 | -$127.00M derived: sum of 3 quarters · filed 2017-02-14 | $53.00M derived: sum of 4 quarters · filed 2017-02-14 |
| 2014-12-31 | $209.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | -$136.00M derived: sum of 2 quarters · filed 2017-02-14 | $44.00M derived: sum of 3 quarters · filed 2017-02-14 | -$136.00M 10-K · filed 2017-02-14 |
| 2014-09-30 | -$345.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | -$165.00M derived: sum of 2 quarters · filed 2015-11-02 | -$345.00M 10-Q · filed 2015-11-02 | -$439.00M derived: sum of 4 quarters · filed 2016-10-31 |
| 2014-06-30 | $180.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $0.00 10-Q · filed 2015-08-05 | -$94.00M derived: sum of 3 quarters · filed 2016-10-31 | -$95.00M derived: sum of 4 quarters · filed 2016-10-31 |
| 2014-03-31 | -$180.00M 10-Q · filed 2015-04-27 | -$274.00M derived: sum of 2 quarters · filed 2016-10-31 | -$275.00M derived: sum of 3 quarters · filed 2016-10-31 | -$123.00M derived: sum of 4 quarters · filed 2016-10-31 |
| 2013-12-31 | -$94.00M derived: 8-K 12 month − 10-Q 9 month · filed 2016-10-31 | -$95.00M derived: sum of 2 quarters · filed 2016-10-31 | $57.00M derived: sum of 3 quarters · filed 2016-10-31 | $38.00M 8-K · filed 2016-10-31 |
| 2013-09-30 | -$1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-29 | $151.00M derived: sum of 2 quarters · filed 2014-10-29 | $132.00M 10-Q · filed 2014-10-29 | -$18.00M derived: sum of 4 quarters · filed 2015-02-19 |
| 2013-06-30 | $152.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $133.00M 10-Q · filed 2014-08-05 | -$17.00M derived: sum of 3 quarters · filed 2015-02-19 | -$28.00M derived: sum of 4 quarters · filed 2015-02-19 |
| 2013-03-31 | -$19.00M 10-Q · filed 2014-04-30 | -$169.00M derived: sum of 2 quarters · filed 2015-02-19 | -$180.00M derived: sum of 3 quarters · filed 2015-02-19 | -$459.00M derived: sum of 4 quarters · filed 2015-02-19 |
| 2012-12-31 | -$150.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-19 | -$161.00M derived: sum of 2 quarters · filed 2015-02-19 | -$440.00M derived: sum of 3 quarters · filed 2015-02-19 | -$348.00M 10-K · filed 2015-02-19 |
| 2012-09-30 | -$11.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-29 | -$290.00M derived: sum of 2 quarters · filed 2013-10-29 | -$198.00M 10-Q · filed 2013-10-29 | -$27.00M derived: sum of 4 quarters · filed 2014-02-24 |
| 2012-06-30 | -$279.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | -$187.00M 10-Q · filed 2013-08-06 | -$16.00M derived: sum of 3 quarters · filed 2014-02-24 | $1.00M derived: sum of 4 quarters · filed 2014-02-24 |
| 2012-03-31 | $92.00M 10-Q · filed 2013-05-03 | $263.00M derived: sum of 2 quarters · filed 2014-02-24 | $280.00M derived: sum of 3 quarters · filed 2014-02-24 | $468.00M derived: sum of 4 quarters · filed 2014-02-24 |
| 2011-12-31 | $171.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-24 | $188.00M derived: sum of 2 quarters · filed 2014-02-24 | $376.00M derived: sum of 3 quarters · filed 2014-02-24 | $557.00M 10-K · filed 2014-02-24 |
| 2011-09-30 | $17.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $205.00M derived: sum of 2 quarters · filed 2012-11-06 | $386.00M 10-Q · filed 2012-11-06 | $279.00M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-06-30 | $188.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | $369.00M 10-Q · filed 2012-08-08 | $262.00M derived: sum of 3 quarters · filed 2013-02-27 | $480.00M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-03-31 | $181.00M 10-Q · filed 2012-05-08 | $74.00M derived: sum of 2 quarters · filed 2013-02-27 | $292.00M derived: sum of 3 quarters · filed 2013-02-27 | $229.00M derived: sum of 4 quarters · filed 2013-02-27 |
| 2010-12-31 | -$107.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $111.00M derived: sum of 2 quarters · filed 2013-02-27 | $48.00M derived: sum of 3 quarters · filed 2013-02-27 | $210.00M 10-K · filed 2013-02-27 |
| 2010-09-30 | $218.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | $155.00M derived: sum of 2 quarters · filed 2011-11-04 | $317.00M 10-Q · filed 2011-11-04 | $95.00M derived: sum of 4 quarters · filed 2012-02-29 |
| 2010-06-30 | -$63.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-08 | $99.00M 10-Q · filed 2011-08-08 | -$123.00M derived: sum of 3 quarters · filed 2012-02-29 | $27.00M derived: sum of 4 quarters · filed 2012-02-29 |
| 2010-03-31 | $162.00M 10-Q · filed 2011-05-10 | -$60.00M derived: sum of 2 quarters · filed 2012-02-29 | $90.00M derived: sum of 3 quarters · filed 2012-02-29 | $262.00M derived: sum of 4 quarters · filed 2012-02-29 |
| 2009-12-31 | -$222.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29 | -$72.00M derived: sum of 2 quarters · filed 2012-02-29 | $100.00M derived: sum of 3 quarters · filed 2012-02-29 | $36.00M 10-K · filed 2012-02-29 |
| 2009-09-30 | $150.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-08 | $322.00M derived: sum of 2 quarters · filed 2010-11-08 | $258.00M 10-Q · filed 2010-11-08 | $209.00M derived: sum of 4 quarters · filed 2011-02-25 |
| 2009-06-30 | $172.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-09 | $108.00M 10-Q · filed 2010-08-09 | $59.00M derived: sum of 3 quarters · filed 2011-02-25 | -$157.00M derived: sum of 4 quarters · filed 2011-02-25 |
| 2009-03-31 | -$64.00M 10-Q · filed 2010-05-07 | -$113.00M derived: sum of 2 quarters · filed 2011-02-25 | -$329.00M derived: sum of 3 quarters · filed 2011-02-25 | |
| 2008-12-31 | -$49.00M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-25 | -$265.00M derived: sum of 2 quarters · filed 2011-02-25 | -$65.00M 10-K · filed 2011-02-25 | |
| 2008-09-30 | -$216.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-11-06 | -$16.00M 10-Q · filed 2009-11-06 | ||
| 2008-06-30 | $200.00M 10-Q · filed 2009-08-10 | |||
| 2007-12-31 | -$38.00M 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GILEAD SCIENCES, INC. (GILD) | United States | $185.522B | -48.37 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |